tradingkey.logo

Vertex Announces UK Mhra Approval Of Alyftrek

ReutersMar 7, 2025 4:32 PM

- Vertex Pharmaceuticals Inc VRTX.O:

  • VERTEX ANNOUNCES UK MHRA APPROVAL OF ALYFTREK® (DEUTIVACAFTOR/TEZACAFTOR/VANZACAFTOR), A ONCE-DAILY NEXT-IN-CLASS CFTR MODULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS

  • VERTEX PHARMACEUTICALS INC - WORKING WITH NICE AND NHS FOR ALYFTREK ACCESS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI